William Pao
-
VU study identifies new gene fusions in melanoma
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. Read MoreDec. 19, 2013
-
Probing mutant EGF receptor regulation
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. Read MoreOct. 10, 2013
-
VU study identifies DNA changes in drug-resistant cancer cells
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read MoreSep. 12, 2013
-
Vanderbilt planning for the future
An executive committee has been named and will meet regularly this summer to develop a framework of ideas to guide a university-wide academic strategic planning process that will set the course for Vanderbilt’s future. Read MoreJul. 5, 2013
-
Foundation lauds graduate student’s melanoma research
Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation. Read MoreMar. 28, 2013
-
New endowed chair holders recognized
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreDec. 20, 2012
-
Nine faculty honored at endowed chair celebration
Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center. Read MoreDec. 13, 2012
-
Photo: Lung Cancer Partnership
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreSep. 27, 2012
-
HER2 may impact lung cancer therapy
A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read MoreSep. 21, 2012
-
Stand Up to Cancer TV broadcast airs Sept. 7
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreAug. 30, 2012
-
Vanderbilt cancer investigators win two national GE cancer research grants
Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read MoreMar. 28, 2012
-
Jeffrey Sosman named to melanoma research ‘Dream Team’
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreDec. 15, 2011
-
Stanley Cohen’s Nobel Prize: 25 years of progress
Twenty-five years after he received the Nobel Prize, Stanley Cohen’s discovery of epidermal growth factor continues to transform medicine. Read MoreDec. 9, 2011
-
Kudos
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreOct. 3, 2011
-
Study suggests new lung cancer therapy schedule
A new lung cancer study led by Vanderbilt-Ingram Cancer Center investigators found that various non-small cell lung cancer cells grow at different rates, which may explain why some tumors become resistant to anti-cancer drugs faster than others. Read MoreAug. 10, 2011
-
Vanderbilt: Laboratory for health care reform
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreApr. 15, 2011
-
Vanderbilt-Ingram Cancer Center launches online genetic research tool
A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials. Read MoreMar. 3, 2011
-
VUCast: New weapon in cancer war
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreJan. 18, 2011
-
Video: VUCast: What is discovery science?
Cancer researchers, led by investigators at Vanderbilt-Ingram Cancer Center, have identified two novel gene fusions in melanoma that may be responsive to existing cancer therapies. Melanoma is the most deadly form of skin cancer. From left, Jeffrey Sosman, M.D., doctoral candidate Katherine Hutchinson and William Pao, M.D.,… Read MoreOct. 15, 2010